Robert W. Pangia, Director at BIOGEN IDEC INC. (BIIB), sold 5,900 shares at $237.23 ($1.4M) on 2013-05-28, disclosed to the SEC on 2013-05-29.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BIIB | SELL | 2017-01-10 | $3.2M | — | Filing → |
| BIIB | SELL | 2015-03-11 | $1.5M | — | Filing → |
| BIIB | SELL | 2014-04-02 | $1.9M | — | Filing → |